keyword
MENU ▼
Read by QxMD icon Read
search

MAD Appliance

keyword
https://www.readbyqxmd.com/read/27329887/-radiographic-study-on-the-efficacy-of-mandibular-advancement-in-patients-with-obstructive-sleep-apnea-syndrome
#1
De-hong Li, Xiang-hong Yang, Jing Zhou, Ling-peng Zhang, Wen Shu
PURPOSE: To investigate the efficacy and mechanism of mandibular advancement device (MAD) treatment on obstructive sleep apnea syndrome (OSAS) patients. METHODS: Eighty OSAS patients treated with a mandibular protraction appliance were included in the study. Three-dimensional reconstruction technique was used as to measure the changes of upper airway structure and volume before and after MAD treatment. The data was analyzed using SPSS 17.0 software package. RESULTS: The anatomic structure and the reinforcement of soft tissue's collapse in the upper airway changed after application of MAD in OSAS patients; velopharyngeal and laryngopharynx configuration was significantly increased (P<0...
April 2016: Shanghai Kou Qiang Yi Xue, Shanghai Journal of Stomatology
https://www.readbyqxmd.com/read/26900249/drug-induced-sleep-endoscopy-as-a-selection-tool-for-mandibular-advancement-therapy-by-oral-device-in-patients-with-mild-to-moderate-obstructive-sleep-apnoea
#2
REVIEW
E De Corso, G Bastanza, G Della Marca, C Grippaudo, G Rizzotto, M R Marchese, A Fiorita, B Sergi, D Meucci, W Di Nardo, G Paludetti, E Scarano
Nowadays oral appliance therapy is recognised as an effective therapy for many patients with primary snoring and mild to moderate obstructive sleep apnoea (OSA), as well as those with more severe OSA who cannot tolerate positive airway pressure (PAP) therapies. For this reason, it is important to focus on objective criteria to indicate which subjects may benefit from treatment with a mandibular advancement device (MAD). Various anthropometric and polysomnographic predictors have been described in the literature, whereas there are still controversies about the role of drug-induced sleep endoscopy (DISE) and advancement bimanual manoeuvre as predictor factors of treatment outcome by oral device...
December 2015: Acta Otorhinolaryngologica Italica
https://www.readbyqxmd.com/read/26585170/management-of-obstructive-sleep-apnea-in-edentulous-patients-an-overview-of-the-literature
#3
REVIEW
David S P Heidsieck, Maurits H T de Ruiter, Jan de Lange
PURPOSE: A high prevalence of obstructive sleep apnea (OSA) is seen in edentulous individuals. Treatment options for edentulous OSA patients however are limited with continuous positive airway pressure therapy (CPAP) remaining the current therapy of choice. As CPAP is associated with high non-adherence rates and oral appliance therapy requiring sufficient dentition, there is a clinical need for effective treatment strategies aimed at edentulous OSA patients. The purpose of this study was to present a thorough overview of the literature regarding (1) the effects of nocturnal denture wearing on OSA, (2) the outcomes of oral appliance therapy, and (3) surgical treatment in edentulous OSA patients...
March 2016: Sleep & Breathing, Schlaf & Atmung
https://www.readbyqxmd.com/read/26483952/treatment-of-obstructive-sleep-apnea-with-mandibular-advancement-appliance-over-prostheses-a-case-report
#4
Thais Moura Guimarães, Sâmia Colen, Paulo Afonso Cunali, Rowdley Rossi, Cibele Dal-Fabbro, Otávio Ferraz, Sergio Tufik, Lia Bittencourt
Treatment with a mandibular advancement device (MAD) is recommended for mild obstructive sleep apnea (OSA), primary snoring and as a secondary option for Continuous Positive Airway Pressure, because it has better adherence and acceptance. However, edentulous patients do not have supports to hold the MAD. This study aimed to present a possible to OSA treatment with MAD in over complete upper and partial lower dentures. The patient, a 38-year-old female with mild OSA, was treated with a MAD. The respiratory parameter, such as apnea-hypopnea index, arousal index and oxyhemoglobin saturation was improved after treatment...
April 2015: Sleep Science
https://www.readbyqxmd.com/read/26004173/evaluation-of-various-treatment-modalities-in-sleep-bruxism
#5
Punit Kumar Singh, Habib A Alvi, Balendra Pratap Singh, Raghuwar D Singh, Surya Kant, Sunit Jurel, Kamleshwar Singh, Deeksha Arya, Abhishek Dubey
STATEMENT OF PROBLEM: Sleep bruxism (SB) is an oral condition that is associated with tooth wear, orofacial pain, and interference with sleep. The most recommended management technique is the use of an occlusal splint. Although the mandibular advancement device (MAD) has shown good results, few well-designed randomized controlled trials are available with which to compare these treatment options. Therefore, an evaluation of the effect of these 2 appliances on SB is needed. PURPOSE: The purpose of this study was to evaluate the effect of a MAD and a maxillary occlusal splint (MOS) on the sleep quality and SB activity of participants with SB...
September 2015: Journal of Prosthetic Dentistry
https://www.readbyqxmd.com/read/25252763/oral-appliances-for-the-treatment-of-obstructive-sleep-apnea-in-patients-with-low-c-pap-compliance-a-long-term-case-series
#6
Rosario Marchese-Ragona, Daniele Manfredini, Marta Mion, Andrea Vianello, Alberto Staffieri, Luca Guarda-Nardini
OBJECTIVES: To assess the effectiveness of mandibular advancement devices (MADs) for the treatment of obstructive sleep apnea syndrome (OSAS) over a long-term follow-up in patients non-compliant with continuous positive airway pressure (CPAP) and to identify potential predictive factors of response to MADs. METHODS: Fifteen OSAS patients were enrolled. Apnea-hypopnea index (AHI) and daytime sleepiness were assessed at baseline and at the end of follow-up. Potential baseline predictors of treatment effectiveness were assessed...
October 2014: Cranio: the Journal of Craniomandibular Practice
https://www.readbyqxmd.com/read/25221854/alternatives-to-continuous-positive-airway-pressure-2-mandibular-advancement-devices-compared
#7
REVIEW
Timothy G Quinnell, Abigail L Clutterbuck-James
PURPOSE OF REVIEW: Although mandibular advancement devices (MADs) provide an alternative to continuous positive airway pressure (CPAP) therapy in obstructive sleep apnea (OSA), their effectiveness and role remain unclear. Several recent studies and an updated meta-analysis have attempted to address these uncertainties. This review examines their contribution to the existing evidence and discusses the future priorities for MAD research. RECENT FINDINGS: Recent work has examined the impact of MAD design on clinical and cost-effectiveness in milder disease...
November 2014: Current Opinion in Pulmonary Medicine
https://www.readbyqxmd.com/read/24969408/a-pilot-study-to-compare-patient-perception-of-obstructive-sleep-apnea-treatment-with-cpap-or-appliance-therapy
#8
RANDOMIZED CONTROLLED TRIAL
Deeksha Arya, Saumyendra Vikram Singh, Arvind Tripathi, Surya Kant Tripathi
STATEMENT OF PROBLEM: The continuous positive airway pressure (CPAP) device yields optimum results in treating mild to moderate obstructive sleep apnea (OSA). However it may be bulky, noisy, and difficult to sleep with for the patient. Mandibular advancement devices (MAD) have shown better compliance but at the expense of lesser efficiency. PURPOSE: The purpose of this study was to evaluate the patient's posttreatment subjective perception of the effectiveness of 2 common treatments of OSA...
November 2014: Journal of Prosthetic Dentistry
https://www.readbyqxmd.com/read/24957654/advances-in-the-treatment-of-obstructive-sleep-apnea
#9
David Young, Nancy Collop
This article focuses on the treatment of obstructive sleep apnea (OSA), using the most recent available data. The first choice of treatment for patients with moderate or severe obstructive sleep apnea is continuous positive airway pressure (CPAP), which was first described in 1981 (Sullivan et al. Lancet 1(8225):862-5, 1981) and works by splinting the airway open to facilitate proper airflow. For patients with mild OSA, other treatments may be considered including positional therapy, weight loss, or oral appliances...
August 2014: Current Treatment Options in Neurology
https://www.readbyqxmd.com/read/24948477/oral-appliance-to-assist-non-invasive-ventilation-in-a-patient-with-amyotrophic-lateral-sclerosis
#10
Steffanie K B Veldhuis, Michiel H J Doff, Boudewijn Stegenga, Jellie A Nieuwenhuis, Peter J Wijkstra
BACKGROUND: From the moment the respiratory muscle groups are affected in amyotrophic lateral sclerosis (ALS), respiratory complications will be the major cause of morbidity and mortality. Untreated respiratory muscle impairment leads to respiratory insufficiency and additionally to difficulties in airway secretion clearance. Non-invasive ventilation (NIV) is the first choice in treating respiratory insufficiency in ALS as it improves sleep-related symptoms, quality of life and life expectancy...
March 2015: Sleep & Breathing, Schlaf & Atmung
https://www.readbyqxmd.com/read/24923216/-comparative-effectiveness-of-maxillomandibular-advancement-surgery-versus-mandibular-advancement-device-for-patients-with-moderate-or-severe-obstructive-sleep-area
#11
COMPARATIVE STUDY
Emilie Garreau, Thomas Wojcik, Julie Bouscaillou, Joël Ferri, Gwenaël Raoul
INTRODUCTION: Currently, positive airway pressure is the gold standard treatment of obstructive sleep apnea (OSA). Unfortunely, adherence rates are poor. Alternative therapies are mandibular advancement device (MAD) and maxillomandibular advancement (MMA). PATIENTS: This retrospective study compared both treatment effectiveness on patients with moderate and severe OSA from January 2005 to September 2012, and carried out predictive factor of effectiveness. We defined therapeutic success as an apnea hypopnea index (AHI) less than 15 per hour and at least a 50% reduction of the initial index...
June 2014: L' Orthodontie Française
https://www.readbyqxmd.com/read/24788696/treatment-of-elderly-patients-with-snoring-and-obstructive-sleep-apnea-using-a-mandibular-advancement-device
#12
COMPARATIVE STUDY
Marie Marklund, Karl A Franklin
INTRODUCTION: The simplicity of oral appliance therapy in the treatment of adult patients with snoring and obstructive sleep apnea (OSA) has resulted in a worldwide interest for this treatment modality. Mandibular advancement devices (MADs) that hold the lower jaw forward during sleep are mainly indicated for patients with milder OSA and those with CPAP intolerance. There has been minor attention on age when suggesting treatment alternatives for patients with OSA. Some studies indicate that there is a weak negative relationship between treatment success from MADs and higher age, but no studies have stratified their samples with respect to age...
March 2015: Sleep & Breathing, Schlaf & Atmung
https://www.readbyqxmd.com/read/24696294/effect-of-oral-appliance-on-endothelial-function-in-sleep-apnea
#13
Ching-Chi Lin, Huey-Yuan Wang, Chung-Hsin Chiu, Shwu-Fang Liaw
OBJECTIVES: This study evaluated the effects of mandibular advancement device (MAD) on serum levels of nitric oxide derivatives and endothelial function by endothelium-dependent flow-mediated dilation (FMD) in obstructive sleep apnea syndrome (OSAS). METHODS: Thirty patients with moderately severe-to-severe OSAS who desired MAD and 15 healthy controls were prospectively enrolled. FMD was measured by high-resolution B-mode ultrasonography, while serum NO x level from peripheral blood samples was measured by ELISA...
March 2015: Clinical Oral Investigations
https://www.readbyqxmd.com/read/24463982/mandibular-advancement-device-and-cpap-upon-cardiovascular-parameters-in-osa
#14
RANDOMIZED CONTROLLED TRIAL
Cibele Dal-Fabbro, Silvério Garbuio, Vânia D'Almeida, Fátima D Cintra, Sergio Tufik, Lia Bittencourt
PURPOSE: This study aims to compare the effects of a mandibular advancement device (MAD) with continuous positive airway pressure (CPAP) treatment for obstructive sleep apnea (OSA) on blood pressure (BP), oxidative stress, and heart rate variability (HRV) in a randomized, crossed-over, single-blind, and controlled trial. METHODS: Twenty-nine moderate-to-severe adult OSA patients underwent MAD, CPAP, and placebo oral appliance treatment. Polysomnography, Epworth sleepiness scale, 24-h ambulatory BP monitoring, oxidative stress parameters (malondialdehyde, catalase, superoxide dismutase, vitamins C, E, B6, B12, folate, homocysteine, uric acid), and HRV were assessed at baseline and after 1 month of each treatment...
December 2014: Sleep & Breathing, Schlaf & Atmung
https://www.readbyqxmd.com/read/24326088/treatment-of-obstructive-sleep-apnea-with-oral-appliances
#15
RANDOMIZED CONTROLLED TRIAL
Andressa Otranto de Britto Teixeira, Luciana Baptista Pereira Abi-Ramia, Marco Antonio de Oliveira Almeida
BACKGROUND: The purpose of this study was to evaluate the effectiveness of mandibular advancement devices (MADs) for treatment of obstructive sleep apnea syndrome (OSAS) compared with the results obtained with a placebo device in accordance with the following indicators: apnea hypopnea index (AHI) per hour of sleep, apnea index (AI) per hour of sleep, mean oxyhemoglobin saturation, sleep efficiency, and percentage of rapid eye movement (REM) sleep. METHODS: This is a controlled, prospective longitudinal study with a follow-up time of 10...
2013: Progress in Orthodontics
https://www.readbyqxmd.com/read/23997711/mandibular-advancement-device-vs-cpap-in-the-treatment-of-obstructive-sleep-apnea-are-they-equally-effective-in-short-term-health-outcomes
#16
COMMENT
David P White, Shirin Shafazand
QUESTION: Is the treatment of obstructive sleep apnea (OSA) with mandibular advancement device (MAD) similar in health outcomes to continuous positive airway pressure (CPAP) in the short term (one month health outcomes)? DESIGN: Randomized, open labeled, cross over, non-inferiority trial; Clinical trial registered with https://www.anzctr.org.au (ACTRN 12607000289415). ALLOCATION: Patients randomized to both the treatment acclimatization and treatment arm orders, resulting in 4 randomized sequences for MAD (M) and CPAP (C): MCMC, MCCM, CMMC and CMCM...
September 15, 2013: Journal of Clinical Sleep Medicine: JCSM: Official Publication of the American Academy of Sleep Medicine
https://www.readbyqxmd.com/read/23971157/effect-of-a-maxillary-appliance-in-an-adult-with-obstructive-sleep-apnea-a-case-report
#17
G Dave Singh, John D Callister
Patients who arrive at the dental office with a diagnosis of obstructive sleep apnea (OSA) are often managed with a mandibular advancement device (MAD). However, the use of MADs has been associated with temporomandibular joint (TMJ) issues. The authors describe a case report of a 64-year-old male who was treated with a novel, maxillary oral appliance. The baseline sleep study indicated an apnea-hypopnea index (AHI) of 25.6/hour with 28 episodes of snoring, and 30.9 oxygen desaturation events/hour. The patient wore the maxillary oral appliance for 10-12 hours/day and night...
July 2013: Cranio: the Journal of Craniomandibular Practice
https://www.readbyqxmd.com/read/23867336/factors-associated-with-the-efficacy-of-mandibular-advancing-device-treatment-in-adult-osa-patients
#18
Francesca Milano, Maria Celeste Billi, Francesca Marra, Giovanni Sorrenti, Antonio Gracco, Giulio A Bonetti
The aim of this study was to evaluate the anthropometric, demographic, occlusal and cephalometric characteristics of a group of adult obstructive sleep apnea (OSA) patients treated with mandibular advancement devices (MADs) and to determine the factors associated with treatment efficacy. Twenty-three consecutive patients with mild to severe OSA (polysomnographically diagnosed [T0]) were recruited for this prospective study; they were treated with a Silensor(®) appliance, and a polysomnographic exam with the MAD in situ was performed 2 to 3 months later (T1) to evaluate MAD's efficacy...
September 2013: International Orthodontics
https://www.readbyqxmd.com/read/23731062/cardiovascular-mortality-in-obstructive-sleep-apnoea-treated-with-continuous-positive-airway-pressure-or-oral-appliance-an-observational-study
#19
Anil Anandam, Monali Patil, Morohunfolu Akinnusi, Philippe Jaoude, Ali A El-Solh
BACKGROUND AND OBJECTIVE: The objective of this study was to evaluate the long-term cardiovascular mortality in patients with severe obstructive sleep apnoea (OSA) treated with either continuous positive airway pressure (CPAP) or mandibular advancing device (MAD). METHODS: A non-concurrent cohort study of 570 subjects with severe OSA (apnoea/hypopnoea index (AHI) ≥ 30/h) and a control group of 269 subjects (AHI < 5/h) were followed up for a median of 79 months (interquartile range 76-88 months)...
November 2013: Respirology: Official Journal of the Asian Pacific Society of Respirology
https://www.readbyqxmd.com/read/23426543/osas-treatment-with-oral-appliance-assessment-of-our-experience-through-the-use-of-a-new-device
#20
COMPARATIVE STUDY
G Gasparini, C Azzuni, F M D Rinaldo, D Cervelli, T M Marianetti, A Sferrazza, S Pelo
BACKGROUND: Obstructive sleep apnea syndrome (OSAS) is defined as repeated episodes of obstruction of the upper airway and oxygen desaturation of the arterial hemoglobin. OSAS is associated with loud snoring, excessive daytime sleepiness, cardiovascular and neurocognitive disease, increase risk of road accidents. AIM: The aim of this study is to evaluate non-surgical therapy for OSAS using a mandibular advancement device (MAD) that provides for lower jaw protrusion and for an adequate vertical opening, that allows for greater airflow...
February 2013: European Review for Medical and Pharmacological Sciences
keyword
keyword
79117
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"